<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
xmlns:EMSArticle="http://webdoc.advanstar.com/rss/module/EMSArticle"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/servlet/ophthalmologytimes_44008.rss?id=44008">

    <title>Ophthalmology Times - General Ophthalmology</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/General+Ophthalmology/Article/list/44008</link>

    <description>General ophthalmology topics including blindness, dry eye, low vision, ocular allergies, as well as
    trauma and uveitis. From pediatrics to elderly. Covers vision correction including laser surgery, complication
    management, case reports &amp; residents.</description>

    <items>
      <rdf:Seq>
        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Difluprednate-is-noninferior-to-prednisolone-data-/ArticleStandard/Article/detail/585657?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/World-Sight-Day-set-for-Oct-8/ArticleStandard/Article/detail/631236?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Kill-kinetics-of-advanced-generation-fluoroquinolo/ArticleStandard/Article/detail/627827?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Wine-Enjoy-some-downtime-at-a-local-vineyard/ArticleStandard/Article/detail/627819?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Fourth-generation-fluoroquinolone-widens-the-choic/ArticleStandard/Article/detail/627820?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Dining-Please-your-appetite-in-Bay-City/ArticleStandard/Article/detail/627826?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/San-Francisco-unmatched-as-a-travel-destination/ArticleStandard/Article/detail/627834?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Besifloxacin-Fluoroquinolone-developed-expressly-f/ArticleStandard/Article/detail/627828?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Proposed-Medicare-rule-released-by-the-Centers-for/ArticleStandard/Article/detail/619332?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Ophthalmology-Knowledge-Assessment-Program-A-rite-/ArticleStandard/Article/detail/617059?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/The-European-Society-of-Cataract-and-Refractive-Su/ArticleStandard/Article/detail/617065?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Blepharitis-prevalence-and-management-studied-in-r/ArticleStandard/Article/detail/617067?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Association-for-Research-in-Vision-and-Ophthalmolo/ArticleStandard/Article/detail/617064?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Permitted-sterilization-techniques-for-surgical-in/ArticleStandard/Article/detail/610901?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Women-in-research-highlighted-by-ophthalmology-fou/ArticleStandard/Article/detail/602849?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Azithromycin-shown-to-work-quickly-to-improve-ante/ArticleStandard/Article/detail/603265?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Levofloxacin-15-shows-significant-aqueous-penetrat/ArticleStandard/Article/detail/603259?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Loteprednoltobramycin-yields-comfort-tolerability/ArticleStandard/Article/detail/603255?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Bromfenac-trial-suggests-possibility-of-twice-dail/ArticleStandard/Article/detail/603260?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Gatifloxacin-is-shown-to-rapidly-eradicate-methici/ArticleStandard/Article/detail/603257?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Topical-nepafenac-efficacy-is-suggested-by-retrosp/ArticleStandard/Article/detail/603262?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Difluprednate-effectiveness-is-evaluated-when-admi/ArticleStandard/Article/detail/603261?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Besifloxacin-effective-against-corneal-bacteria/ArticleStandard/Article/detail/603258?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Ophthalmologys-underserved-areas-to-be-addressed-b/ArticleStandard/Article/detail/599641?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Computer-based-software-used-to-visualize-in-vivo-/ArticleStandard/Article/detail/597257?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/OCT-criteria-offer-favorable-performance-in-discri/ArticleStandard/Article/detail/597253?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Iris-tumor-size-is-key-indicator-for-determining-l/ArticleStandard/Article/detail/593675?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Most-recent-fluoroquinolones-bolster-antimicrobial/ArticleStandard/Article/detail/593676?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Ophthalmologist-returns-to-competitive-golf/ArticleStandard/Article/detail/593686?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Disparities-in-eye-care-to-be-examined-by-the-Asso/ArticleStandard/Article/detail/593674?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Perioperative-ketorolac-significantly-reduces-cyst/ArticleStandard/Article/detail/589238?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Topical-corticosteroid-loteprednol-improves-with-e/ArticleStandard/Article/detail/589240?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Besifloxacin-effectively-treats-gram-positive-and-/ArticleStandard/Article/detail/589244?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/The-Association-for-Research-in-Vision-and-Ophthal/ArticleStandard/Article/detail/589235?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Topical-gatifloxacin-trial-suggests-minimal-benefi/ArticleStandard/Article/detail/589239?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Analysis-Keeping-the-big-picture-in-mind/ArticleStandard/Article/detail/589236?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Pseudomonas-among-most-virulent-of-corneal-pathoge/ArticleStandard/Article/detail/589245?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Topical-azithromycin-is-shown-to-help-improve-post/ArticleStandard/Article/detail/589241?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Intracameral-moxifloxacin-preferred-for-antibacter/ArticleStandard/Article/detail/589237?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Nepafenac-regimens-demonstrate-efficacy-in-control/ArticleStandard/Article/detail/589242?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/RGN-259-promotes-healing-in-patients-with-non-heal/ArticleStandard/Article/detail/589243?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/Skin-moles-may-indicate-a-higher-risk-for-eye-mela/ArticleStandard/Article/detail/585457?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cultural-flair-of-San-Francisco-is-unmatched-world/ArticleStandard/Article/detail/585652?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Enjoy-some-downtime-at-a-local-vineyard/ArticleStandard/Article/detail/585654?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Please-your-appetite-in-San-Fran/ArticleStandard/Article/detail/585653?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/A-complete-guide-to-travel-in-San-Francisco/ArticleStandard/Article/detail/583900?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Annual-Wilmer-Vail-meeting-set-for-March-16-to-20/ArticleStandard/Article/detail/582489?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Cataract+News/Cataract-refractive-surgeons-become-editorial-advi/ArticleStandard/Article/detail/574459?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Association-for-Research-in-Vision-and-Ophthalmolo/ArticleStandard/Article/detail/572052?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Ketotifen-drop-designed-to-provide-ocular-itching-/ArticleStandard/Article/detail/560432?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Questions-remain-regarding-antibacterial-therapy/ArticleStandard/Article/detail/560431?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Take-a-new-look-at-existing-devices-surgeon-sugges/ArticleStandard/Article/detail/560433?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Standardized-language-describes-trauma-to-globe/ArticleStandard/Article/detail/560434?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/E-mail-can-be-integrated-into-ophthalmic-practice/ArticleStandard/Article/detail/560430?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/HIV-drugs-needed-globally-to-control-disease-long-/ArticleStandard/Article/detail/560421?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Into-Africa-Clinic-brings-eye-care/ArticleStandard/Article/detail/559863?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/The-Association-for-Research-in-Vision-and-Ophthal/ArticleStandard/Article/detail/559862?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Consider-masquerade-syndromes-when-a-differential-/ArticleStandard/Article/detail/556875?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/The-Association-for-Research-and-Vision-in-Ophthal/ArticleStandard/Article/detail/551967?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Simplicity-of-instrument-design-yields-complete-pa/ArticleStandard/Article/detail/551977?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Decontamination-of-surgical-instruments-is-no-plac/ArticleStandard/Article/detail/551969?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Device-simplifies-challenges-of-pterygium-surgery/ArticleStandard/Article/detail/552112?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/IOL-cutter-small-size-strength-boons-to-IOL-explan/ArticleStandard/Article/detail/551975?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Knives-offer-diamond-sharpness-in-single-use-packa/ArticleStandard/Article/detail/551970?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Titanium-calipers-life-long-accuracy-without-defor/ArticleStandard/Article/detail/551971?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Studies-still-weighing-supplements-for-tear-dysfun/ArticleStandard/Article/detail/551979?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Limbal-relaxing-incision-kit-simplifies-task-of-tr/ArticleStandard/Article/detail/551972?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Each-instrument-category-requires-different-type-o/ArticleStandard/Article/detail/551974?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Steam-most-widely-used-method-of-sterilization/ArticleStandard/Article/detail/551973?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Instrument-care-takes-on-greater-importance-in-tox/ArticleStandard/Article/detail/551968?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Marker-knife-useful-additions-to-refractive-catara/ArticleStandard/Article/detail/551978?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/One-grape-at-a-time/ArticleStandard/Article/detail/552114?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Intraocular-forceps-enable-alternative-Descemet-st/ArticleStandard/Article/detail/551976?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Eyes-on-Hollywood-Ophthalmologist-finds-success-in/ArticleStandard/Article/detail/548877?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Ultrasound-provides-clearer-picture-of-posterior-s/ArticleStandard/Article/detail/544808?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Refractive/Confocal-microscopy-yields-higher-resolution-image/ArticleStandard/Article/detail/544818?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Manual-and-automated-iris-boundary-detection-provi/ArticleStandard/Article/detail/544817?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/A-new-view-on-imaging-the-anterior-segment/ArticleStandard/Article/detail/544815?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Retinal+Disease/3-D-optical-coherence-tomography-gaining-ground-bu/ArticleStandard/Article/detail/544811?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Cornea+Feature/Optical-coherence-tomography-a-useful-addition-to-/ArticleStandard/Article/detail/544820?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Retinal+Disease/New-technology-offers-promise-for-patients-with-ag/ArticleStandard/Article/detail/544810?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Instrument-analyzes-biomechanical-function-of-tiss/ArticleStandard/Article/detail/544819?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Association-for-Research-in-Vision-and-Ophthalmolo/ArticleStandard/Article/detail/544806?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Fourier-domain-optical-coherence-tomography-allows/ArticleStandard/Article/detail/544812?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Scheimpflug-camera-useful-as-no-history-method-for/ArticleStandard/Article/detail/544821?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Azithromycin-solution-shows-efficacy-for-treating-/ArticleStandard/Article/detail/544807?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Glaucoma+Feature/Spectral-domain-optical-coherence-tomography-produ/ArticleStandard/Article/detail/544816?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Glaucoma+Feature/Automated-system-separates-glaucomatous-healthy-ey/ArticleStandard/Article/detail/544814?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Refractive/Screening-not-foolproof-for-avoiding-post-LASIK-ec/ArticleStandard/Article/detail/544813?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Spectral-domain-optical-coherence-tomography-an-im/ArticleStandard/Article/detail/544809?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Network-seeks-to-provide-DNA-samples-for-eye-disea/ArticleStandard/Article/detail/533866?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Increase-of-receptor-for-advanced-glycation-end-pr/ArticleStandard/Article/detail/533937?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Berlin-unites-ophthalmologists-from-the-East-and-W/ArticleStandard/Article/detail/533857?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Orchestrating-international-health/ArticleStandard/Article/detail/530363?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Insurance-deductibles-the-impact-on-patient-care/ArticleStandard/Article/detail/526998?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Survey-assesses-life-quality-for-adults-with-strab/ArticleStandard/Article/detail/526997?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Vision-loss-studies-aim-to-optimize-future-care-fo/ArticleStandard/Article/detail/525445?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Through-the-eyes-of-a-collector/ArticleStandard/Article/detail/525464?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/New-tool-extends-patient-education-process-beyond-/ArticleStandard/Article/detail/525446?contextCategoryId=44008&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/K7WX-calling/ArticleStandard/Article/detail/522120?contextCategoryId=44008&amp;ref=25" />
      </rdf:Seq>
    </items>

    <dc:date>2009-11-21T17:19:47Z</dc:date>
  </channel>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Difluprednate-is-noninferior-to-prednisolone-data-/ArticleStandard/Article/detail/585657?contextCategoryId=44008&amp;ref=25">

    <title>Difluprednate is noninferior to prednisolone, data show</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Difluprednate-is-noninferior-to-prednisolone-data-/ArticleStandard/Article/detail/585657?contextCategoryId=44008&amp;ref=25</link>

    <description>Difluprednate ophthalmic emulsion 0.05% (Durezol, Sirion Therapeutics) was comparable with
    prednisolone ophthalmic suspension 1% (Pred Forte, Allergan), the current standard of care, in a pivotal anterior
    uveitis trial. Difluprednate was dosed four times daily compared with eight times for prednisolone acetate,
    suggesting that it could enhance compliance.</description>

    <dc:date>2009-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/102009/585657null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/World-Sight-Day-set-for-Oct-8/ArticleStandard/Article/detail/631236?contextCategoryId=44008&amp;ref=25">

    <title>World Sight Day set for Oct. 8</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/World-Sight-Day-set-for-Oct-8/ArticleStandard/Article/detail/631236?contextCategoryId=44008&amp;ref=25</link>

    <description>Three hundred events in more than 50 countries will mark this year's World Sight Day, Oct.
    8.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/412009/631236null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Kill-kinetics-of-advanced-generation-fluoroquinolo/ArticleStandard/Article/detail/627827?contextCategoryId=44008&amp;ref=25">

    <title>Kill kinetics of advanced-generation fluoroquinolones compared in study</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Kill-kinetics-of-advanced-generation-fluoroquinolo/ArticleStandard/Article/detail/627827?contextCategoryId=44008&amp;ref=25</link>

    <description>An in vitro kill kinetics study evaluated eradication of 18 human ocular Staphylococcus isolates by
    commercial formulations of gatifloxacin 0.3% (Zymar, Allergan) and moxifloxacin 0.5% (Vigamox, Alcon Laboratories).
    Gatifloxacin demonstrated superior activity, which may be attributed to the presence of benzalkonium chloride
    0.005% in its formulation.</description>

    <dc:date>2009-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/382009/627827null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Wine-Enjoy-some-downtime-at-a-local-vineyard/ArticleStandard/Article/detail/627819?contextCategoryId=44008&amp;ref=25">

    <title>Wine: Enjoy some downtime at a local vineyard</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Wine-Enjoy-some-downtime-at-a-local-vineyard/ArticleStandard/Article/detail/627819?contextCategoryId=44008&amp;ref=25</link>

    <description>Napa and Sonoma counties, located approximately an hour from San Francisco, are well known around the
    United States and the world for their superior wine and wineries.</description>

    <dc:date>2009-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/382009/627819null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Fourth-generation-fluoroquinolone-widens-the-choic/ArticleStandard/Article/detail/627820?contextCategoryId=44008&amp;ref=25">

    <title>Fourth-generation fluoroquinolone widens the choice of antibiotic</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Fourth-generation-fluoroquinolone-widens-the-choic/ArticleStandard/Article/detail/627820?contextCategoryId=44008&amp;ref=25</link>

    <description>The introduction of a new fourth-generation fluoroquinolone for ophthalmic use may prompt an
    assessment of the pros and cons of the available agents. James P. McCulley, MD, explains his continued preference
    for moxifloxacin 0.5% (Vigamox, Alcon).</description>

    <dc:date>2009-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/382009/627820null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Dining-Please-your-appetite-in-Bay-City/ArticleStandard/Article/detail/627826?contextCategoryId=44008&amp;ref=25">

    <title>Dining: Please your appetite in Bay City</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Dining-Please-your-appetite-in-Bay-City/ArticleStandard/Article/detail/627826?contextCategoryId=44008&amp;ref=25</link>

    <description>San Francisco has cuisine to satisfy many taste buds. From dim sum to gnocchi, use this guide to map
    out your dining tour of the city by the bay.</description>

    <dc:date>2009-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/382009/627826null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/San-Francisco-unmatched-as-a-travel-destination/ArticleStandard/Article/detail/627834?contextCategoryId=44008&amp;ref=25">

    <title>San Francisco unmatched as a travel destination</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/San-Francisco-unmatched-as-a-travel-destination/ArticleStandard/Article/detail/627834?contextCategoryId=44008&amp;ref=25</link>

    <description>San Francisco is nearly synonymous with a high cost of living. The advent and financial success of the
    early years of the Internet revolution still lures high-income folks to the city by the bay. Property values and
    household income are among the top in the nation, which enables a profitable restaurant and entertainment
    scene.</description>

    <dc:date>2009-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/382009/627834null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Besifloxacin-Fluoroquinolone-developed-expressly-f/ArticleStandard/Article/detail/627828?contextCategoryId=44008&amp;ref=25">

    <title>Besifloxacin: Fluoroquinolone developed expressly for ophthalmic use</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Besifloxacin-Fluoroquinolone-developed-expressly-f/ArticleStandard/Article/detail/627828?contextCategoryId=44008&amp;ref=25</link>

    <description>Besifloxacin is the first chlorinated fluoroquinolone developed especially for use in the
    eye.</description>

    <dc:date>2009-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/382009/627828null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Proposed-Medicare-rule-released-by-the-Centers-for/ArticleStandard/Article/detail/619332?contextCategoryId=44008&amp;ref=25">

    <title>Proposed Medicare rule released by the Centers for Medicare and Medicaid Services</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Proposed-Medicare-rule-released-by-the-Centers-for/ArticleStandard/Article/detail/619332?contextCategoryId=44008&amp;ref=25</link>

    <description>As members of Congress return home for August recess, the nation's dialogue continues over how best to
    provide health-care coverage to 44 million uninsured Americans.</description>

    <dc:date>2009-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/342009/619332null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Ophthalmology-Knowledge-Assessment-Program-A-rite-/ArticleStandard/Article/detail/617059?contextCategoryId=44008&amp;ref=25">

    <title>Ophthalmology Knowledge Assessment Program: A rite of passage for residents</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Ophthalmology-Knowledge-Assessment-Program-A-rite-/ArticleStandard/Article/detail/617059?contextCategoryId=44008&amp;ref=25</link>

    <description>One resident wonders, what does your Ophthalmology Knowledge Assessment Program score say to others
    about you as a resident? With the exception of applying to oculoplastics fellowships, in the global scheme of
    things, it may make no difference. On the other hand, some residents wished they had done better because they would
    have been thought of more positively within their program.</description>

    <dc:date>2009-08-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/322009/617059null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/The-European-Society-of-Cataract-and-Refractive-Su/ArticleStandard/Article/detail/617065?contextCategoryId=44008&amp;ref=25">

    <title>The European Society of Cataract and Refractive Surgeons journeys to Barcelona for XXVII Congress</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/The-European-Society-of-Cataract-and-Refractive-Su/ArticleStandard/Article/detail/617065?contextCategoryId=44008&amp;ref=25</link>

    <description>The European Society of Cataract and Refractive Surgeons will hold its XXVII Congress from Saturday,
    Sept. 12, through Wednesday, Sept. 16, in this Spanish city located on the Mediterranean coast.</description>

    <dc:date>2009-08-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/322009/617065null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Blepharitis-prevalence-and-management-studied-in-r/ArticleStandard/Article/detail/617067?contextCategoryId=44008&amp;ref=25">

    <title>Blepharitis prevalence and management studied in recent surveys</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Blepharitis-prevalence-and-management-studied-in-r/ArticleStandard/Article/detail/617067?contextCategoryId=44008&amp;ref=25</link>

    <description>Recent surveys of patients and eye care specialists were undertaken to obtain information about the
    prevalence and management of blepharitis. Survey results together with clinical trial data highlight use of topical
    azithromycin.</description>

    <dc:date>2009-08-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/322009/617067null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Association-for-Research-in-Vision-and-Ophthalmolo/ArticleStandard/Article/detail/617064?contextCategoryId=44008&amp;ref=25">

    <title>Association for Research in Vision and Ophthalmology meeting highlights new therapeutics</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Association-for-Research-in-Vision-and-Ophthalmolo/ArticleStandard/Article/detail/617064?contextCategoryId=44008&amp;ref=25</link>

    <description>The 2009 Association for Research in Vision and Ophthalmology annual meeting highlighted research on
    the latest therapeutics in retinal disease, dry eye, lid margin disease, ocular allergies, and other
    conditions.</description>

    <dc:date>2009-08-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/322009/617064null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Permitted-sterilization-techniques-for-surgical-in/ArticleStandard/Article/detail/610901?contextCategoryId=44008&amp;ref=25">

    <title>Permitted sterilization techniques for surgical instruments clarified by Joint Commission</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Permitted-sterilization-techniques-for-surgical-in/ArticleStandard/Article/detail/610901?contextCategoryId=44008&amp;ref=25</link>

    <description>Steam sterilization processes are acceptable methods of preparing operating room instruments as long
    as the manufacturers' instructions are followed, according to a clarification issued June 15 by the Joint
    Commission, a national accreditation and certification body for hospitals and ambulatory surgical
    centers.</description>

    <dc:date>2009-07-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/292009/610901null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Women-in-research-highlighted-by-ophthalmology-fou/ArticleStandard/Article/detail/602849?contextCategoryId=44008&amp;ref=25">

    <title>Women in research highlighted by ophthalmology foundation</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Women-in-research-highlighted-by-ophthalmology-fou/ArticleStandard/Article/detail/602849?contextCategoryId=44008&amp;ref=25</link>

    <description>The newest program of the ARVO Foundation for Eye Research is Women in Eye and Vision Research,
    launched at the Association for Research in Vision and Ophthalmology's 2009 annual meeting to further develop and
    strengthen the career paths of women who conduct eye and vision research.</description>

    <dc:date>2009-06-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/242009/602849null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Azithromycin-shown-to-work-quickly-to-improve-ante/ArticleStandard/Article/detail/603265?contextCategoryId=44008&amp;ref=25">

    <title>Azithromycin shown to work quickly to improve anterior, posterior blepharitis</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Azithromycin-shown-to-work-quickly-to-improve-ante/ArticleStandard/Article/detail/603265?contextCategoryId=44008&amp;ref=25</link>

    <description>Azithromycin ophthalmic solution 1% (AzaSite, Inspire Pharmaceuticals), a broad-spectrum antibiotic
    that has the propensity to penetrate into the ocular tissues, rapidly improves anterior blepharitis faster than any
    other treatments for blepharitis, according to one ophthalmologist.</description>

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/242009/603265null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Levofloxacin-15-shows-significant-aqueous-penetrat/ArticleStandard/Article/detail/603259?contextCategoryId=44008&amp;ref=25">

    <title>Levofloxacin 1.5% shows significant aqueous penetration at three of four time points</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Levofloxacin-15-shows-significant-aqueous-penetrat/ArticleStandard/Article/detail/603259?contextCategoryId=44008&amp;ref=25</link>

    <description>An active comparator, parallel group study comparing levofloxacin 1.5% and moxifloxacin 0.5% in
    patients undergoing cataract surgery showed significantly greater aqueous penetration of levofloxacin, measured as
    area under the curve over a 6-hour interval. Levofloxacin also had a significantly higher Cmax and significantly
    higher maximum concentration at the end of the dose interval. These findings indicate a possible role for
    levofloxacin in the prophylaxis of endophthalmitis at the time of cataract surgery.</description>

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/242009/603259null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Loteprednoltobramycin-yields-comfort-tolerability/ArticleStandard/Article/detail/603255?contextCategoryId=44008&amp;ref=25">

    <title>Loteprednol/tobramycin yields comfort, tolerability</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Loteprednoltobramycin-yields-comfort-tolerability/ArticleStandard/Article/detail/603255?contextCategoryId=44008&amp;ref=25</link>

    <description>Loteprednol etabonate 0.5%/tobramycin 0.3% ([LE/T]; Zylet, Bausch &amp;amp;amp; Lomb) was found to be
    superior to dexamethasone 0.1%/tobramycin 0.3% ([DM/T]; Tobradex, Alcon Laboratories) in a comparison study that
    tested ocular comfort and tolerability in healthy volunteers. LE/T also has shown to be less likely to cause
    increases in IOP levels compared with DM/T. LE/T may provide some small advantages, possibly resulting from
    formulation differences and/or the steroid used, the researchers concluded.</description>

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/242009/603255null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Bromfenac-trial-suggests-possibility-of-twice-dail/ArticleStandard/Article/detail/603260?contextCategoryId=44008&amp;ref=25">

    <title>Bromfenac trial suggests possibility of twice-daily corticosteroid dosing</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Bromfenac-trial-suggests-possibility-of-twice-dail/ArticleStandard/Article/detail/603260?contextCategoryId=44008&amp;ref=25</link>

    <description>A prospective, randomized, investigator-masked study was conducted to compare twice-daily and
    four-times-daily dosing of a corticosteroid after cataract surgery. All patients also received bromfenac 0.09%
    (Xibrom, Ista Pharmaceuticals). No significant differences in macular thickening or anterior chamber cell and flare
    were observed between groups.</description>

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/242009/603260null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Gatifloxacin-is-shown-to-rapidly-eradicate-methici/ArticleStandard/Article/detail/603257?contextCategoryId=44008&amp;ref=25">

    <title>Gatifloxacin is shown to rapidly eradicate methicillin-resistant Staphylococcus aureus clinical isolates,
    according to study</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Gatifloxacin-is-shown-to-rapidly-eradicate-methici/ArticleStandard/Article/detail/603257?contextCategoryId=44008&amp;ref=25</link>

    <description>A study evaluating eradication of methicillin-resistant Staphylococcus aureus (MRSA) by
    fluoroquinolones shows that the commercially available preparation of gatifloxacin 0.3% (Zymar, Allergan) has
    superior bactericidal activity compared with the commercially available preparation of moxifloxacin 0.5% (Vigamox,
    Alcon). Gatifloxacin was more active than moxifloxacin alone, and its activity was enhanced by the presence of the
    preservative benzalkonium chloride.</description>

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/242009/603257null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Topical-nepafenac-efficacy-is-suggested-by-retrosp/ArticleStandard/Article/detail/603262?contextCategoryId=44008&amp;ref=25">

    <title>Topical nepafenac efficacy is suggested by retrospective study</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Topical-nepafenac-efficacy-is-suggested-by-retrosp/ArticleStandard/Article/detail/603262?contextCategoryId=44008&amp;ref=25</link>

    <description>A retrospective study analyzed outcomes in 18 patients who were treated for idiopathic or
    post-cataract surgery cystoid macular edema with nepafenac 0.1% (Nevanac, Alcon Laboratories) alone or combined
    with a corticosteroid. Statistically significant improvements were achieved in mean visual acuity and foveal
    thickness in both groups.</description>

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/242009/603262null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Difluprednate-effectiveness-is-evaluated-when-admi/ArticleStandard/Article/detail/603261?contextCategoryId=44008&amp;ref=25">

    <title>Difluprednate effectiveness is evaluated when administered four times daily</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Difluprednate-effectiveness-is-evaluated-when-admi/ArticleStandard/Article/detail/603261?contextCategoryId=44008&amp;ref=25</link>

    <description>Difluprednate ophthalmic emulsion 0.05% (Durezol, Sirion Therapeutics) was at least as effective as
    prednisolone acetate suspension 1% (Pred Forte, Allergan), dosed twice as often, in the treatment of endogenous
    anterior uveitis. Equivalent effectiveness with less-frequent dosing could improve patient compliance, according to
    one ophthalmologist.</description>

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/242009/603261null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Besifloxacin-effective-against-corneal-bacteria/ArticleStandard/Article/detail/603258?contextCategoryId=44008&amp;ref=25">

    <title>Besifloxacin effective against corneal bacteria</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Besifloxacin-effective-against-corneal-bacteria/ArticleStandard/Article/detail/603258?contextCategoryId=44008&amp;ref=25</link>

    <description>Besifloxacin (Optura, Bausch &amp;amp;amp; Lomb) was found to be more effective than gatifloxacin and
    moxifloxacin in reducing the number of methicillin-resistant Staphylococcus aureus organisms in the cornea when
    applied topically 10 to 18 hours after infection.</description>

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/242009/603258null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Ophthalmologys-underserved-areas-to-be-addressed-b/ArticleStandard/Article/detail/599641?contextCategoryId=44008&amp;ref=25">

    <title>Ophthalmology's underserved areas to be addressed by pharmaceutical pipeline</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Ophthalmologys-underserved-areas-to-be-addressed-b/ArticleStandard/Article/detail/599641?contextCategoryId=44008&amp;ref=25</link>

    <description>The pharmaceutical pipeline is addressing many underserved areas of ophthalmology, such as dry
    age-related macular degeneration (AMD) and dry eye, and new compounds are being studied to replace or augment the
    variety of therapeutics already available for wet AMD and glaucoma.</description>

    <dc:date>2009-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/222009/599641null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Computer-based-software-used-to-visualize-in-vivo-/ArticleStandard/Article/detail/597257?contextCategoryId=44008&amp;ref=25">

    <title>Computer-based software used to visualize in vivo human lens morphology, density</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Computer-based-software-used-to-visualize-in-vivo-/ArticleStandard/Article/detail/597257?contextCategoryId=44008&amp;ref=25</link>

    <description>A model under development for in vivo visualization of human lens morphology could have clinical
    applications in patients at risk for changes in lens transparency. The device, which uses a rotating camera,
    creates a three-dimensional model of the lens and uses the relationship between contrast sensitivity measurements
    and lens optical density to evaluate visual function.</description>

    <dc:date>2009-04-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/192009/597257null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/OCT-criteria-offer-favorable-performance-in-discri/ArticleStandard/Article/detail/597253?contextCategoryId=44008&amp;ref=25">

    <title>OCT criteria offer favorable performance in discriminating ODE from ONHD</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/OCT-criteria-offer-favorable-performance-in-discri/ArticleStandard/Article/detail/597253?contextCategoryId=44008&amp;ref=25</link>

    <description>Analyses of optical coherence tomography images from eyes with established diagnoses of optic nerve
    head drusen or optic disc edema and unaffected controls showed qualitative and quantitative criteria had reasonable
    sensitivity and specificity for discriminating between the two pathologies.</description>

    <dc:date>2009-04-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/192009/597253null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Iris-tumor-size-is-key-indicator-for-determining-l/ArticleStandard/Article/detail/593675?contextCategoryId=44008&amp;ref=25">

    <title>Iris tumor size is key indicator for determining level of concern</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Iris-tumor-size-is-key-indicator-for-determining-l/ArticleStandard/Article/detail/593675?contextCategoryId=44008&amp;ref=25</link>

    <description>Iris tumors are rare and mostly benign. Only a few types of iris lesions are malignant, and anatomical
    features as well as signs and symptoms can aid clinicians in identifying them.</description>

    <dc:date>2009-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/162009/593675null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Most-recent-fluoroquinolones-bolster-antimicrobial/ArticleStandard/Article/detail/593676?contextCategoryId=44008&amp;ref=25">

    <title>Most recent fluoroquinolones bolster antimicrobial armamentarium</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Most-recent-fluoroquinolones-bolster-antimicrobial/ArticleStandard/Article/detail/593676?contextCategoryId=44008&amp;ref=25</link>

    <description>Although the newest fluoroquinolones increasingly are used as the antimicrobial of choice for
    prophylaxis and treatment of serious ocular infections, they should not be relied on to treat established
    infections caused by methicillin-resistant Staphylococcus aureus, fluoroquinolone-resistant bacteria, or atypical
    Mycobacteria. Treatment of fungal ocular infections continues to be a challenge.</description>

    <dc:date>2009-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/162009/593676null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Ophthalmologist-returns-to-competitive-golf/ArticleStandard/Article/detail/593686?contextCategoryId=44008&amp;ref=25">

    <title>Ophthalmologist returns to competitive golf</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Ophthalmologist-returns-to-competitive-golf/ArticleStandard/Article/detail/593686?contextCategoryId=44008&amp;ref=25</link>

    <description>Dr. Newsom grew up in coastal Virginia, playing golf with his father and brother, and attended East
    Carolina University on a golf scholarship. But during medical school, his residency, and subsequent years, little
    time was left for golf. Happily, he now is well established in his career and can pursue excellence in golf
    parallel to his success in ophthalmology.</description>

    <dc:date>2009-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/162009/593686null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Disparities-in-eye-care-to-be-examined-by-the-Asso/ArticleStandard/Article/detail/593674?contextCategoryId=44008&amp;ref=25">

    <title>Disparities in eye care to be examined by the Association for Research in Vision and Ophthalmology</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Disparities-in-eye-care-to-be-examined-by-the-Asso/ArticleStandard/Article/detail/593674?contextCategoryId=44008&amp;ref=25</link>

    <description>More than 10,000 vision professionals are expected to attend the 2009 annual meeting of the
    Association for Research in Vision and Ophthalmology (ARVO) here from Sunday, May 3 to Thursday, May
    7.</description>

    <dc:date>2009-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/162009/593674null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Perioperative-ketorolac-significantly-reduces-cyst/ArticleStandard/Article/detail/589238?contextCategoryId=44008&amp;ref=25">

    <title>Perioperative ketorolac significantly reduces cystoid macular edema, macular thickening after phaco, study
    finds</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Perioperative-ketorolac-significantly-reduces-cyst/ArticleStandard/Article/detail/589238?contextCategoryId=44008&amp;ref=25</link>

    <description>A prospective, randomized, investigator-masked clinical trial randomly assigned 546 patients without
    risk factors for postoperative cystoid macular edema (CME) to receive postoperative treatment with a corticosteroid
    alone or combined with ketorolac tromethamine 0.4% (Acular LS, Allergan) in an extended perioperative/postoperative
    regimen. The addition of ketorolac had statistically significant benefits for reducing the incidences of CME
    (diagnosed clinically and by OCT) and macular thickening.</description>

    <dc:date>2009-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/132009/589238null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Topical-corticosteroid-loteprednol-improves-with-e/ArticleStandard/Article/detail/589240?contextCategoryId=44008&amp;ref=25">

    <title>Topical corticosteroid loteprednol improves with ester group substitution</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Topical-corticosteroid-loteprednol-improves-with-e/ArticleStandard/Article/detail/589240?contextCategoryId=44008&amp;ref=25</link>

    <description>Replacement of ketone moieties with an ester group in the formulation of the topical corticosteroid
    loteprednol etabonate ophthalmic suspension 0.5% (Lotemax, Bausch &amp;amp;amp; Lomb) has clinical benefits not
    only in the original agent but in the combination corticosteroid-antibiotic loteprednol etabonate 0.5% and
    tobramycin 0.3% ophthalmic suspension (Zylet, Bausch &amp;amp;amp; Lomb), according to three
    ophthalmologists.</description>

    <dc:date>2009-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/132009/589240null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Besifloxacin-effectively-treats-gram-positive-and-/ArticleStandard/Article/detail/589244?contextCategoryId=44008&amp;ref=25">

    <title>Besifloxacin effectively treats gram-positive and gram-negative bacteria</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Besifloxacin-effectively-treats-gram-positive-and-/ArticleStandard/Article/detail/589244?contextCategoryId=44008&amp;ref=25</link>

    <description>Many antibiotics are used to treat ocular bacterial infections and it seems as though fluoroquinolones
    are the most effective. The results of a recent study show, however, that besifloxacin is particularly effective in
    killing both gram-positive and gram-negative bacteria, possibly making it the drug of choice, according to one
    expert.</description>

    <dc:date>2009-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/132009/589244null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/The-Association-for-Research-in-Vision-and-Ophthal/ArticleStandard/Article/detail/589235?contextCategoryId=44008&amp;ref=25">

    <title>The Association for Research in Vision and Ophthalmology introduces 'fellow' designation</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/The-Association-for-Research-in-Vision-and-Ophthal/ArticleStandard/Article/detail/589235?contextCategoryId=44008&amp;ref=25</link>

    <description>The Association for Research in Vision and Ophthalmology (ARVO) will introduce the inaugural class of
    Fellows of ARVO (FARVO) at its annual meeting, May 3 to 7 in Fort Lauderdale, FL.</description>

    <dc:date>2009-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/132009/589235null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Topical-gatifloxacin-trial-suggests-minimal-benefi/ArticleStandard/Article/detail/589239?contextCategoryId=44008&amp;ref=25">

    <title>Topical gatifloxacin trial suggests minimal benefit of antibiotic use</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Topical-gatifloxacin-trial-suggests-minimal-benefi/ArticleStandard/Article/detail/589239?contextCategoryId=44008&amp;ref=25</link>

    <description>The effect of topical gatifloxacin 0.3% (Zymar, Allergan) for reducing injection-site contamination
    prior to intravitreal injection was investigated in a prospective controlled clinical trial. The results showed
    that a 3-day application of gatifloxacin resulted in significant reduction in conjunctival bacterial flora, but no
    additional benefit was seen when the procedure preparation included povidone-iodine.</description>

    <dc:date>2009-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/132009/589239null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Analysis-Keeping-the-big-picture-in-mind/ArticleStandard/Article/detail/589236?contextCategoryId=44008&amp;ref=25">

    <title>Analysis: Keeping the big picture in mind</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Analysis-Keeping-the-big-picture-in-mind/ArticleStandard/Article/detail/589236?contextCategoryId=44008&amp;ref=25</link>

    <description>Many ophthalmology residents choose to pursue a fellowship for the desire to acquire specialized
    skills. However, there is the need to pull back and remember that one is a doctor first and an ophthalmologist
    second. This applies not only to ophthalmic manifestations of systemic disease, such as diabetic retinopathy, but
    also to understanding the totality of a patient's circumstances.</description>

    <dc:date>2009-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/132009/589236null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Pseudomonas-among-most-virulent-of-corneal-pathoge/ArticleStandard/Article/detail/589245?contextCategoryId=44008&amp;ref=25">

    <title>Pseudomonas among most virulent of corneal pathogens</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Pseudomonas-among-most-virulent-of-corneal-pathoge/ArticleStandard/Article/detail/589245?contextCategoryId=44008&amp;ref=25</link>

    <description>Three decades years ago, Pseudomonas was considered the most challenging cause of keratitis. Its
    leading role has been usurped for various reasons by other pathogens, including methicillin-resistant
    Staphylococcus aureus, fungi, and Acanthamoeba.</description>

    <dc:date>2009-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/132009/589245null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Topical-azithromycin-is-shown-to-help-improve-post/ArticleStandard/Article/detail/589241?contextCategoryId=44008&amp;ref=25">

    <title>Topical azithromycin is shown to help improve posterior blepharitis</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Topical-azithromycin-is-shown-to-help-improve-post/ArticleStandard/Article/detail/589241?contextCategoryId=44008&amp;ref=25</link>

    <description>Results of a 14-day, open-label, controlled pilot trial showed that adding topical azithromycin 1%
    ophthalmic solution (AzaSite, Inspire Pharmaceuticals) to a standard mechanical therapy regimen for treatment of
    posterior blepharitis can provide dramatic and rapid improvements in the signs and symptoms of lid margin
    disease.</description>

    <dc:date>2009-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/132009/589241null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Intracameral-moxifloxacin-preferred-for-antibacter/ArticleStandard/Article/detail/589237?contextCategoryId=44008&amp;ref=25">

    <title>Intracameral moxifloxacin preferred for antibacterial prophylaxis in cataract surgery</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Intracameral-moxifloxacin-preferred-for-antibacter/ArticleStandard/Article/detail/589237?contextCategoryId=44008&amp;ref=25</link>

    <description>Moxifloxacin has become the antibiotic of choice because of its broad-spectrum coverage, which yields
    high efficacy in preventing endophthalmitis in intraocular surgeries. According to one expert, moxifloxacin is the
    preferred choice for intracameral antibiotic prophylaxis in ocular surgery because it proves to be superior to
    other antibiotic agents previously used.</description>

    <dc:date>2009-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/132009/589237null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Nepafenac-regimens-demonstrate-efficacy-in-control/ArticleStandard/Article/detail/589242?contextCategoryId=44008&amp;ref=25">

    <title>Nepafenac regimens demonstrate efficacy in controlling postop pain and inflammation</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Nepafenac-regimens-demonstrate-efficacy-in-control/ArticleStandard/Article/detail/589242?contextCategoryId=44008&amp;ref=25</link>

    <description>A prospective, multicenter, randomized, double-masked, vehicle-controlled clinical trial of 212
    patients investigated the efficacy and safety of nepafenac 0.1% ophthalmic suspension q.d., b.i.d., and t.i.d. for
    controlling pain and inflammation after cataract surgery. All three regimens were significantly superior to vehicle
    in the primary efficacy analysis. The t.i.d. dosing offered the fastest onset of action, but the b.i.d. and q.d.
    regimens demonstrated significant efficacy early after surgery as well.</description>

    <dc:date>2009-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/132009/589242null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/RGN-259-promotes-healing-in-patients-with-non-heal/ArticleStandard/Article/detail/589243?contextCategoryId=44008&amp;ref=25">

    <title>RGN-259 promotes healing in patients with non-healing corneal ulcers</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/RGN-259-promotes-healing-in-patients-with-non-heal/ArticleStandard/Article/detail/589243?contextCategoryId=44008&amp;ref=25</link>

    <description>An ophthalmic drug candidate based on the naturally occurring peptide thymosin beta 4 has been used to
    treat several patients with neurotrophic keratitis and non-healing ulcers under a compassionate use investigational
    new drug application. All of the ulcers healed completely or demonstrated significant improvement. The experimental
    drug, RGN-259 (RegeneRx Biopharmaceuticals Inc.), also could have potential in treating corneal wounds and related
    disorders.</description>

    <dc:date>2009-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/132009/589243null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/Skin-moles-may-indicate-a-higher-risk-for-eye-mela/ArticleStandard/Article/detail/585457?contextCategoryId=44008&amp;ref=25">

    <title>Skin moles may indicate a higher risk for eye melanoma</title>

    <link>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/Skin-moles-may-indicate-a-higher-risk-for-eye-mela/ArticleStandard/Article/detail/585457?contextCategoryId=44008&amp;ref=25</link>

    <description>There may be an association between atypical moles, common moles, freckles, moles on the iris, and
    risk of melanoma, according to a study.</description>

    <dc:date>2009-03-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/102009/585457null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cultural-flair-of-San-Francisco-is-unmatched-world/ArticleStandard/Article/detail/585652?contextCategoryId=44008&amp;ref=25">

    <title>Cultural flair of San Francisco is unmatched worldwide</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cultural-flair-of-San-Francisco-is-unmatched-world/ArticleStandard/Article/detail/585652?contextCategoryId=44008&amp;ref=25</link>

    <description>San Francisco is nearly synonymous with a high cost of living. The advent and financial success of the
    early years of the Internet revolution still lures high-income folks to the city by the bay. Property values and
    household income are among the top in the nation, which enables a profitable restaurant and entertainment
    scene.</description>

    <dc:date>2009-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/102009/585652null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Enjoy-some-downtime-at-a-local-vineyard/ArticleStandard/Article/detail/585654?contextCategoryId=44008&amp;ref=25">

    <title>Enjoy some downtime at a local vineyard</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Enjoy-some-downtime-at-a-local-vineyard/ArticleStandard/Article/detail/585654?contextCategoryId=44008&amp;ref=25</link>

    <description>Napa and Sonoma counties, located approximately an hour from San Francisco, are well known around the
    United States and the world for their superior wine and wineries. Here is just a sampling of the local
    vineyards.</description>

    <dc:date>2009-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/102009/585654null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Please-your-appetite-in-San-Fran/ArticleStandard/Article/detail/585653?contextCategoryId=44008&amp;ref=25">

    <title>Please your appetite in San Fran</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Please-your-appetite-in-San-Fran/ArticleStandard/Article/detail/585653?contextCategoryId=44008&amp;ref=25</link>

    <description>San Francisco has cuisine to satisfy many taste buds. From dim sum to gnocchi, use this guide to map
    out your dining tour of the city by the bay.</description>

    <dc:date>2009-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/102009/585653null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/A-complete-guide-to-travel-in-San-Francisco/ArticleStandard/Article/detail/583900?contextCategoryId=44008&amp;ref=25">

    <title>A complete guide to travel in San Francisco</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/A-complete-guide-to-travel-in-San-Francisco/ArticleStandard/Article/detail/583900?contextCategoryId=44008&amp;ref=25</link>

    <description>A complete guide to travel in San Francisco when you go to the American Society of Cataract and
    Refractive Surgery annual meeting.</description>

    <dc:date>2009-02-27T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/092009/583900null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Annual-Wilmer-Vail-meeting-set-for-March-16-to-20/ArticleStandard/Article/detail/582489?contextCategoryId=44008&amp;ref=25">

    <title>Annual Wilmer Vail meeting set for March 16 to 20</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Annual-Wilmer-Vail-meeting-set-for-March-16-to-20/ArticleStandard/Article/detail/582489?contextCategoryId=44008&amp;ref=25</link>

    <description>The Wilmer Eye Institute will host its 26th annual Current Concepts in Ophthalmology meeting here
    March 16 to 20.</description>

    <dc:date>2009-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/082009/582489null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Cataract+News/Cataract-refractive-surgeons-become-editorial-advi/ArticleStandard/Article/detail/574459?contextCategoryId=44008&amp;ref=25">

    <title>Cataract, refractive surgeons become editorial advisors to patient education Web sites</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Cataract+News/Cataract-refractive-surgeons-become-editorial-advi/ArticleStandard/Article/detail/574459?contextCategoryId=44008&amp;ref=25</link>

    <description>Medical Management Services Group LLC have appointed both cataract and refractive surgeons as
    editorial advisors for 2009.</description>

    <dc:date>2009-01-08T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/022009/574459null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Association-for-Research-in-Vision-and-Ophthalmolo/ArticleStandard/Article/detail/572052?contextCategoryId=44008&amp;ref=25">

    <title>Association for Research in Vision and Ophthalmology names recipients of 2009 awards</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Association-for-Research-in-Vision-and-Ophthalmolo/ArticleStandard/Article/detail/572052?contextCategoryId=44008&amp;ref=25</link>

    <description>Five scientists will receive awards from the Association for Research in Vision and Ophthalmology in
    2009. Four of them will deliver lectures at the organization's annual meeting, May 3 to 7 in Fort Lauderdale,
    FL.</description>

    <dc:date>2008-12-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/512008/572052null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Ketotifen-drop-designed-to-provide-ocular-itching-/ArticleStandard/Article/detail/560432?contextCategoryId=44008&amp;ref=25">

    <title>Ketotifen drop designed to provide ocular itching relief</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Ketotifen-drop-designed-to-provide-ocular-itching-/ArticleStandard/Article/detail/560432?contextCategoryId=44008&amp;ref=25</link>

    <description>A new ketotifen fumarate ophthalmic solution (Refresh Eye Itch Relief, Allergan) offers patients
    another option for the treatment of episodic ocular itching as well as seasonal and chronic allergic
    conjunctivitis.</description>

    <dc:date>2008-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/560432null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Questions-remain-regarding-antibacterial-therapy/ArticleStandard/Article/detail/560431?contextCategoryId=44008&amp;ref=25">

    <title>Questions remain regarding antibacterial therapy</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Questions-remain-regarding-antibacterial-therapy/ArticleStandard/Article/detail/560431?contextCategoryId=44008&amp;ref=25</link>

    <description>Times have changed, and, with them, practices in antibacterial therapy. Questions remain, however. Has
    progress been made over the decades, and what does the future hold?</description>

    <dc:date>2008-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/560431null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Take-a-new-look-at-existing-devices-surgeon-sugges/ArticleStandard/Article/detail/560433?contextCategoryId=44008&amp;ref=25">

    <title>Take a new look at existing devices, surgeon suggests</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Take-a-new-look-at-existing-devices-surgeon-sugges/ArticleStandard/Article/detail/560433?contextCategoryId=44008&amp;ref=25</link>

    <description>The high-tech devices available today are changing the way ophthalmology is practiced. According to
    the surgeon, the new technology found in state-of-the-art optical coherence tomography goes much further than
    assisting ophthalmologists in the diagnostics of anterior eye and retinal disorders.</description>

    <dc:date>2008-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/560433null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Standardized-language-describes-trauma-to-globe/ArticleStandard/Article/detail/560434?contextCategoryId=44008&amp;ref=25">

    <title>Standardized language describes trauma to globe</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Standardized-language-describes-trauma-to-globe/ArticleStandard/Article/detail/560434?contextCategoryId=44008&amp;ref=25</link>

    <description>Using standardized terminology, such as that in the Birmingham Eye Trauma Terminology system, to
    describe trauma to the globe eliminates misrepresentation of the injury.</description>

    <dc:date>2008-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/560434null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/E-mail-can-be-integrated-into-ophthalmic-practice/ArticleStandard/Article/detail/560430?contextCategoryId=44008&amp;ref=25">

    <title>E-mail can be integrated into ophthalmic practice</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/E-mail-can-be-integrated-into-ophthalmic-practice/ArticleStandard/Article/detail/560430?contextCategoryId=44008&amp;ref=25</link>

    <description>Physicians seem to have grasped the power of the Internet to help them secure continuing medical
    education credits in a way that precisely meets their professional interests and time constraints.</description>

    <dc:date>2008-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/560430null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/HIV-drugs-needed-globally-to-control-disease-long-/ArticleStandard/Article/detail/560421?contextCategoryId=44008&amp;ref=25">

    <title>HIV drugs needed globally to control disease long term</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/HIV-drugs-needed-globally-to-control-disease-long-/ArticleStandard/Article/detail/560421?contextCategoryId=44008&amp;ref=25</link>

    <description>Human immunodeficiency virus (HIV) has become a manageable chronic disease, but that is true only in
    rich countries that have a relatively small number of HIV cases. With the evolution of treatment, patients can
    expect a natural life expectancy with the available therapies. These treatments are needed globally in third-world
    countries where most of the cases are.</description>

    <dc:date>2008-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/560421null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Into-Africa-Clinic-brings-eye-care/ArticleStandard/Article/detail/559863?contextCategoryId=44008&amp;ref=25">

    <title>Into Africa: Clinic brings eye care</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Into-Africa-Clinic-brings-eye-care/ArticleStandard/Article/detail/559863?contextCategoryId=44008&amp;ref=25</link>

    <description>Like many ophthalmologists in this country, Cathy Schanzer, MD, feels a responsibility to share her
    talents and skills to help the less fortunate through mission work. Dr. Schanzer, however, was not satisfied with a
    yearly mission trip. Today, she devotes her spare time to supporting and working 2 months each year at the eye
    clinic she established in Sierra Leone, West Africa.</description>

    <dc:date>2008-10-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/559863null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/The-Association-for-Research-in-Vision-and-Ophthal/ArticleStandard/Article/detail/559862?contextCategoryId=44008&amp;ref=25">

    <title>The Association for Research in Vision and Ophthalmology hosts several events at the American Academy of
    Ophthalmology/the European Society of Ophthalmologists joint meeting in Atlanta</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/The-Association-for-Research-in-Vision-and-Ophthal/ArticleStandard/Article/detail/559862?contextCategoryId=44008&amp;ref=25</link>

    <description>The Association for Research in Vision and Ophthalmology (ARVO) will be organizing two events at the
    2008 Joint Meeting of the American Academy of Ophthalmology (AAO) and the European Society of Ophthalmology in
    Atlanta in November. ARVO is also supporting the participation of the National Alliance for Eye and Vision Research
    (NAEVR) in a third session.</description>

    <dc:date>2008-10-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/559862null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Consider-masquerade-syndromes-when-a-differential-/ArticleStandard/Article/detail/556875?contextCategoryId=44008&amp;ref=25">

    <title>Consider masquerade syndromes when a differential diagnosis appears to indicate idiopathic uveitis</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Consider-masquerade-syndromes-when-a-differential-/ArticleStandard/Article/detail/556875?contextCategoryId=44008&amp;ref=25</link>

    <description>When making a differential diagnosis of idiopathic uveitis, remember that several malignant and
    non-malignant syndromes can masquerade as the condition. Making the correct diagnosis early allows prompt
    institution of appropriate therapy and avoids unnecessary treatment.</description>

    <dc:date>2008-10-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/412008/556875null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/The-Association-for-Research-and-Vision-in-Ophthal/ArticleStandard/Article/detail/551967?contextCategoryId=44008&amp;ref=25">

    <title>The Association for Research and Vision in Ophthalmology and the National Alliance for Eye and Vision
    Research work to keep Congress up to date</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/The-Association-for-Research-and-Vision-in-Ophthal/ArticleStandard/Article/detail/551967?contextCategoryId=44008&amp;ref=25</link>

    <description>Most of the Association for Research in Vision and Ophthalmology's advocacy efforts in the United
    States take the form of educating members of Congress about the work its members do to help prevent and cure vision
    disorders and blindness.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551967null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Simplicity-of-instrument-design-yields-complete-pa/ArticleStandard/Article/detail/551977?contextCategoryId=44008&amp;ref=25">

    <title>Simplicity of instrument design yields complete package</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Simplicity-of-instrument-design-yields-complete-pa/ArticleStandard/Article/detail/551977?contextCategoryId=44008&amp;ref=25</link>

    <description>A set of four instruments for cataract surgery (Devgan Cataract Set, Bausch &amp;amp;amp; Lomb Storz
    Instruments) simplifies the needs of surgeons.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551977null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Decontamination-of-surgical-instruments-is-no-plac/ArticleStandard/Article/detail/551969?contextCategoryId=44008&amp;ref=25">

    <title>Decontamination of surgical instruments is no place to cut corners</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Decontamination-of-surgical-instruments-is-no-plac/ArticleStandard/Article/detail/551969?contextCategoryId=44008&amp;ref=25</link>

    <description>Proper decontamination of microsurgical ophthalmic instruments takes time and effort and is not a
    place for shortcuts.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551969null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Device-simplifies-challenges-of-pterygium-surgery/ArticleStandard/Article/detail/552112?contextCategoryId=44008&amp;ref=25">

    <title>Device simplifies challenges of pterygium surgery</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Device-simplifies-challenges-of-pterygium-surgery/ArticleStandard/Article/detail/552112?contextCategoryId=44008&amp;ref=25</link>

    <description>A new device ensures flap orientation during pterygium removals (Sabet Pterygium Flap Maintainer,
    Rhein Medical).</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/552112null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/IOL-cutter-small-size-strength-boons-to-IOL-explan/ArticleStandard/Article/detail/551975?contextCategoryId=44008&amp;ref=25">

    <title>IOL cutter small size, strength boons to IOL explantation procedure</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/IOL-cutter-small-size-strength-boons-to-IOL-explan/ArticleStandard/Article/detail/551975?contextCategoryId=44008&amp;ref=25</link>

    <description>A proprietary IOL cutter (Packer/Chang IOL Cutter, Microsurgical Technology) is a micro-scissors that
    can be inserted through a paracentesis incision while the surgeon holds the optic with a forceps through the
    phacoemulsification incision. The instrument facilitates safe removal of IOLs.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551975null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Knives-offer-diamond-sharpness-in-single-use-packa/ArticleStandard/Article/detail/551970?contextCategoryId=44008&amp;ref=25">

    <title>Knives offer diamond sharpness in single-use package</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Knives-offer-diamond-sharpness-in-single-use-packa/ArticleStandard/Article/detail/551970?contextCategoryId=44008&amp;ref=25</link>

    <description>A line of single-use, silicon surgical knives (BD Atomic Edge Safety Knives, BD
    Medical&amp;amp;mdash;Ophthalmic Systems) offers benefits for patients, ophthalmologists, and health-care
    workers.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551970null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Titanium-calipers-life-long-accuracy-without-defor/ArticleStandard/Article/detail/551971?contextCategoryId=44008&amp;ref=25">

    <title>Titanium calipers: life-long accuracy without deforming</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Titanium-calipers-life-long-accuracy-without-defor/ArticleStandard/Article/detail/551971?contextCategoryId=44008&amp;ref=25</link>

    <description>A proprietary titanium caliper (Steiner Titanium Caliper, Stronger Medical Instruments) was designed
    to maintain accurate measurements and resist deforming of the tips even after numerous cycles of
    cleaning.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551971null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Studies-still-weighing-supplements-for-tear-dysfun/ArticleStandard/Article/detail/551979?contextCategoryId=44008&amp;ref=25">

    <title>Studies still weighing supplements for tear dysfunction</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Studies-still-weighing-supplements-for-tear-dysfun/ArticleStandard/Article/detail/551979?contextCategoryId=44008&amp;ref=25</link>

    <description>Supplementation with omega-3 fatty acids, omega-6 fatty acids, and fish oils in patients with dry eye
    probably will decrease the overall inflammatory state of the eye based on subjective evidence, but objective
    placebo-controlled trials should be conducted to validate this recommendation.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551979null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Limbal-relaxing-incision-kit-simplifies-task-of-tr/ArticleStandard/Article/detail/551972?contextCategoryId=44008&amp;ref=25">

    <title>Limbal relaxing incision kit simplifies task of treating residual astigmatism</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Limbal-relaxing-incision-kit-simplifies-task-of-tr/ArticleStandard/Article/detail/551972?contextCategoryId=44008&amp;ref=25</link>

    <description>The Donnenfeld Limbal Relaxing Incision (LRI) kit (Accutome) contains a set of tools to simplify LRI
    surgery, including the Donnenfeld LRI Diamond Knife that enables patient treatment at the slit-lamp.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551972null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Each-instrument-category-requires-different-type-o/ArticleStandard/Article/detail/551974?contextCategoryId=44008&amp;ref=25">

    <title>Each instrument category requires different type of care</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Each-instrument-category-requires-different-type-o/ArticleStandard/Article/detail/551974?contextCategoryId=44008&amp;ref=25</link>

    <description>Proper care of surgical instruments is essential to patient safety and surgical
    outcomes.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551974null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Steam-most-widely-used-method-of-sterilization/ArticleStandard/Article/detail/551973?contextCategoryId=44008&amp;ref=25">

    <title>Steam most widely used method of sterilization</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Steam-most-widely-used-method-of-sterilization/ArticleStandard/Article/detail/551973?contextCategoryId=44008&amp;ref=25</link>

    <description>Several sterilization methods can be used for microsurgical instruments, although steam remains the
    most widely used method.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551973null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Instrument-care-takes-on-greater-importance-in-tox/ArticleStandard/Article/detail/551968?contextCategoryId=44008&amp;ref=25">

    <title>Instrument care takes on greater importance in toxic anterior segment syndrome era</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Instrument-care-takes-on-greater-importance-in-tox/ArticleStandard/Article/detail/551968?contextCategoryId=44008&amp;ref=25</link>

    <description>In the age of toxic anterior segment syndrome, proper care of ophthalmic surgical instruments is of
    even greater importance to patient safety.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551968null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Marker-knife-useful-additions-to-refractive-catara/ArticleStandard/Article/detail/551978?contextCategoryId=44008&amp;ref=25">

    <title>Marker, knife useful additions to refractive cataract surgeons' armamentarium</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Marker-knife-useful-additions-to-refractive-catara/ArticleStandard/Article/detail/551978?contextCategoryId=44008&amp;ref=25</link>

    <description>Two new instruments designed by Y. Ralph Chu, MD, and available from Katena Eye Instruments are useful
    aids for cataract surgeons performing limbal relaxing incisions.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551978null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/One-grape-at-a-time/ArticleStandard/Article/detail/552114?contextCategoryId=44008&amp;ref=25">

    <title>One grape at a time</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/One-grape-at-a-time/ArticleStandard/Article/detail/552114?contextCategoryId=44008&amp;ref=25</link>

    <description>David M. Dillman, MD, a wine enthusiast and ophthalmologist, is driven by both to understand how
    things work, is fascinated by the details, and loves the challenge of keeping up with constant
    change.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/552114null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Intraocular-forceps-enable-alternative-Descemet-st/ArticleStandard/Article/detail/551976?contextCategoryId=44008&amp;ref=25">

    <title>Intraocular forceps enable alternative Descemet stripping automated endothelial keratoplasty transplantation
    technique</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Intraocular-forceps-enable-alternative-Descemet-st/ArticleStandard/Article/detail/551976?contextCategoryId=44008&amp;ref=25</link>

    <description>The new Descemet stripping automated endothelial keratoplasty transplantation technique in which the
    surgeon pulls the donor cornea through without folding, rather than pushing it with the forceps, helps to prevent
    damage to the endothelial. ASICO's forceps have a firm grip without sharp points and a single shaft to easily
    maneuver in a small area.</description>

    <dc:date>2008-09-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551976null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Eyes-on-Hollywood-Ophthalmologist-finds-success-in/ArticleStandard/Article/detail/548877?contextCategoryId=44008&amp;ref=25">

    <title>Eyes on Hollywood: Ophthalmologist finds success in high-profile media projects</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Eyes-on-Hollywood-Ophthalmologist-finds-success-in/ArticleStandard/Article/detail/548877?contextCategoryId=44008&amp;ref=25</link>

    <description>Rolando Toyos, MD, surgeon and founder of Toyos Clinic in Memphis, TN, is a well-known local
    personality. He has been in television commercials for his own clinic and appears on local news to discuss issues
    related to ophthalmology.</description>

    <dc:date>2008-09-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/372008/548877null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Ultrasound-provides-clearer-picture-of-posterior-s/ArticleStandard/Article/detail/544808?contextCategoryId=44008&amp;ref=25">

    <title>Ultrasound provides clearer picture of posterior segment</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Ultrasound-provides-clearer-picture-of-posterior-s/ArticleStandard/Article/detail/544808?contextCategoryId=44008&amp;ref=25</link>

    <description>Ultrasound still has a place in ophthalmology. Several new developments in the technology facilitate
    detailed visualization of the posterior segment.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544808null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Refractive/Confocal-microscopy-yields-higher-resolution-image/ArticleStandard/Article/detail/544818?contextCategoryId=44008&amp;ref=25">

    <title>Confocal microscopy yields higher-resolution images</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Refractive/Confocal-microscopy-yields-higher-resolution-image/ArticleStandard/Article/detail/544818?contextCategoryId=44008&amp;ref=25</link>

    <description>Confocal microscopy can be used for refractive surgery to address concerns regarding wound healing and
    the interface, especially when assessing different techniques. The technology also can be used to assess problems
    after LASIK regarding dry eye.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544818null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Manual-and-automated-iris-boundary-detection-provi/ArticleStandard/Article/detail/544817?contextCategoryId=44008&amp;ref=25">

    <title>Manual and automated iris boundary detection provide accurate methodology for ablation centration</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Manual-and-automated-iris-boundary-detection-provi/ArticleStandard/Article/detail/544817?contextCategoryId=44008&amp;ref=25</link>

    <description>A recent study assessed the consistency and repeatability of skilled refractive surgeons in detecting
    the iris boundary from the infrared camera of a proprietary excimer laser (STAR S4 IR, Advanced Medical Optics) and
    used as a gold standard for evaluating the platform's automated system. Results show that both methods provide a
    level of centration accuracy consistent with quality vision results.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544817null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/A-new-view-on-imaging-the-anterior-segment/ArticleStandard/Article/detail/544815?contextCategoryId=44008&amp;ref=25">

    <title>A new view on imaging the anterior segment</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/A-new-view-on-imaging-the-anterior-segment/ArticleStandard/Article/detail/544815?contextCategoryId=44008&amp;ref=25</link>

    <description>A new version of an ophthalmic ultrasound system has the unique ability to image all aspects of the
    anterior segment. As a key differentiator to optical coherence tomography, the ultrasound system, which has a
    high-frequency B-probe, enables the user to see behind the iris and create dynamic movies rather than static
    images.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544815null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Retinal+Disease/3-D-optical-coherence-tomography-gaining-ground-bu/ArticleStandard/Article/detail/544811?contextCategoryId=44008&amp;ref=25">

    <title>3-D optical coherence tomography gaining ground, but 2-D optical coherence tomography may be
    mainstay</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Retinal+Disease/3-D-optical-coherence-tomography-gaining-ground-bu/ArticleStandard/Article/detail/544811?contextCategoryId=44008&amp;ref=25</link>

    <description>Three-dimensional optical coherence tomography (OCT) has improved on the speed with which scans are
    obtained and has added more detailed information about the retina in various retinal diseases. Two-dimensional OCT,
    however, should remain a staple in retinal practice for some time to come.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544811null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Cornea+Feature/Optical-coherence-tomography-a-useful-addition-to-/ArticleStandard/Article/detail/544820?contextCategoryId=44008&amp;ref=25">

    <title>Optical coherence tomography a useful addition to clinical practice, doctor finds</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Cornea+Feature/Optical-coherence-tomography-a-useful-addition-to-/ArticleStandard/Article/detail/544820?contextCategoryId=44008&amp;ref=25</link>

    <description>A proprietary device for optical coherence tomography (Visante, Carl Zeiss Meditec) seems to be a
    highly useful addition to clinical practice. The instrument, according to one physician, may be the best resource
    thus far to evaluate placement of intracorneal segments, femtosecond laser-enabled keratoplasty, and penetrating
    keratoplasty.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544820null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Retinal+Disease/New-technology-offers-promise-for-patients-with-ag/ArticleStandard/Article/detail/544810?contextCategoryId=44008&amp;ref=25">

    <title>New technology offers promise for patients with age-related macular degeneration</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Retinal+Disease/New-technology-offers-promise-for-patients-with-ag/ArticleStandard/Article/detail/544810?contextCategoryId=44008&amp;ref=25</link>

    <description>An in-office test is offering hope for many patients with age-related macular
    degeneration.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544810null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Instrument-analyzes-biomechanical-function-of-tiss/ArticleStandard/Article/detail/544819?contextCategoryId=44008&amp;ref=25">

    <title>Instrument analyzes biomechanical function of tissue</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Instrument-analyzes-biomechanical-function-of-tiss/ArticleStandard/Article/detail/544819?contextCategoryId=44008&amp;ref=25</link>

    <description>Proprietary instrumentation (Ocular Response Analyzer, Reichert Ophthalmic Instruments) is useful in
    ophthalmology, but the current generation of the instrument may have some limitations, according to one
    physician.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544819null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Association-for-Research-in-Vision-and-Ophthalmolo/ArticleStandard/Article/detail/544806?contextCategoryId=44008&amp;ref=25">

    <title>Association for Research in Vision and Ophthalmology preview: Courses aim to help ensure state-of-the-art
    clinical trials</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Association-for-Research-in-Vision-and-Ophthalmolo/ArticleStandard/Article/detail/544806?contextCategoryId=44008&amp;ref=25</link>

    <description>Clinical trials are advancing frequently, which is why the Association for Research in Vision and
    Ophthalmology is offering a series of courses to help eye researchers keep up.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544806null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Fourier-domain-optical-coherence-tomography-allows/ArticleStandard/Article/detail/544812?contextCategoryId=44008&amp;ref=25">

    <title>Fourier-domain optical coherence tomography allows improved visualization of retinal layers</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Fourier-domain-optical-coherence-tomography-allows/ArticleStandard/Article/detail/544812?contextCategoryId=44008&amp;ref=25</link>

    <description>Fourier-domain optical coherence tomography allows detailed visualization of the retinal layers,
    especially the photoreceptor layer.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544812null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Scheimpflug-camera-useful-as-no-history-method-for/ArticleStandard/Article/detail/544821?contextCategoryId=44008&amp;ref=25">

    <title>Scheimpflug camera useful as no-history method for determining corneal power in post-LASIK eyes</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Scheimpflug-camera-useful-as-no-history-method-for/ArticleStandard/Article/detail/544821?contextCategoryId=44008&amp;ref=25</link>

    <description>Images from a rotating Scheimpflug camera (Pentacam, Oculus) provide less accurate information on
    corneal power in post-LASIK eyes than methods involving adjustment based on the amount of laser correction, but the
    imaging device represents a useful tool when clinical history data are not available, according to the results of a
    retrospective study.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544821null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Azithromycin-solution-shows-efficacy-for-treating-/ArticleStandard/Article/detail/544807?contextCategoryId=44008&amp;ref=25">

    <title>Azithromycin solution shows efficacy for treating patients with blepharitis</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Azithromycin-solution-shows-efficacy-for-treating-/ArticleStandard/Article/detail/544807?contextCategoryId=44008&amp;ref=25</link>

    <description>Independent studies show promising potential of topical azithromycin 1% ophthalmic solution (AzaSite,
    Inspire Pharmaceuticals) for the treatment of both posterior and chronic anterior blepharitis.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544807null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Glaucoma+Feature/Spectral-domain-optical-coherence-tomography-produ/ArticleStandard/Article/detail/544816?contextCategoryId=44008&amp;ref=25">

    <title>Spectral domain-optical coherence tomography produces better results of retinal nerve fiber thickness
    imaging than scanning laser polarimetry, study shows</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Glaucoma+Feature/Spectral-domain-optical-coherence-tomography-produ/ArticleStandard/Article/detail/544816?contextCategoryId=44008&amp;ref=25</link>

    <description>A recent study using a high-resolution spectral-domain optical coherence tomography (SD-OCT) to image
    and quantify retinal nerve fiber (RNF) loss in patients with glaucoma showed superior imaging results when compared
    with the imaging of a scanning laser polarimetry (SLP) device.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544816null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Glaucoma+Feature/Automated-system-separates-glaucomatous-healthy-ey/ArticleStandard/Article/detail/544814?contextCategoryId=44008&amp;ref=25">

    <title>Automated system separates glaucomatous, healthy eyes</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Glaucoma+Feature/Automated-system-separates-glaucomatous-healthy-ey/ArticleStandard/Article/detail/544814?contextCategoryId=44008&amp;ref=25</link>

    <description>An automated glaucoma risk indicator using digital color fundus photos proved to be accurate in the
    detection of glaucoma disease in a recent study. This novel technique is not intended to replace other
    state-of-the-art diagnostic techniques currently used . Ophthalmologists, however, can receive a confirmation from
    this automated diagnosing system that the diagnosis they are making in regards to glaucoma is the right
    one.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544814null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Refractive/Screening-not-foolproof-for-avoiding-post-LASIK-ec/ArticleStandard/Article/detail/544813?contextCategoryId=44008&amp;ref=25">

    <title>Screening not foolproof for avoiding post-LASIK ectasia</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Refractive/Screening-not-foolproof-for-avoiding-post-LASIK-ec/ArticleStandard/Article/detail/544813?contextCategoryId=44008&amp;ref=25</link>

    <description>Several preoperative features have been identified as important risk factors for ectasia after laser
    refractive surgery, particularly in patients undergoing LASIK for high myopia or myopic astigmatism. This
    complication can occur in the absence of any of these findings, however.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544813null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Spectral-domain-optical-coherence-tomography-an-im/ArticleStandard/Article/detail/544809?contextCategoryId=44008&amp;ref=25">

    <title>Spectral-domain optical coherence tomography an improvement over previous optical coherence tomography
    systems</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Spectral-domain-optical-coherence-tomography-an-im/ArticleStandard/Article/detail/544809?contextCategoryId=44008&amp;ref=25</link>

    <description>Spectral-domain optical coherence tomography (SD-OCT) offers several major advantages over
    conventional OCT: faster image acquisition time, improved resolution, and improved image processing. In addition,
    the technology decreases patient motion artifact, which is especially useful when obtaining images in
    children.</description>

    <dc:date>2008-08-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/544809null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Network-seeks-to-provide-DNA-samples-for-eye-disea/ArticleStandard/Article/detail/533866?contextCategoryId=44008&amp;ref=25">

    <title>Network seeks to provide DNA samples for eye disease</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Network-seeks-to-provide-DNA-samples-for-eye-disea/ArticleStandard/Article/detail/533866?contextCategoryId=44008&amp;ref=25</link>

    <description>The National Ophthalmic Disease Genotyping Network (eyeGENE), developed in 2007 by the National Eye
    Institute, is a repository of inherited eye disease DNA samples that can be used anonymously for research. The hope
    is that eyeGENE will facilitate discovery of new ophthalmic disease genes, help researchers identify genetic
    modifiers of disease, and enhance patient enrollment in clinical trials.</description>

    <dc:date>2008-08-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/322008/533866null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Increase-of-receptor-for-advanced-glycation-end-pr/ArticleStandard/Article/detail/533937?contextCategoryId=44008&amp;ref=25">

    <title>Increase of receptor for advanced glycation end products in axons, glial cells of optic nerves associated
    with Alzheimer's, research suggests</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Increase-of-receptor-for-advanced-glycation-end-pr/ArticleStandard/Article/detail/533937?contextCategoryId=44008&amp;ref=25</link>

    <description>Immunohistochemical studies have shown that the receptor for advanced glycation end products (RAGE) is
    elevated in the optic nerves of patients with Alzheimer's disease. Future studies are expected to provide more
    information about the role of RAGE in Alzheimer's disease and other neurodegenerative diseases and could lead to
    new therapeutic options if RAGE is determined to be a causative agent.</description>

    <dc:date>2008-08-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/322008/533937null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Berlin-unites-ophthalmologists-from-the-East-and-W/ArticleStandard/Article/detail/533857?contextCategoryId=44008&amp;ref=25">

    <title>Berlin unites ophthalmologists from the East and West</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Berlin-unites-ophthalmologists-from-the-East-and-W/ArticleStandard/Article/detail/533857?contextCategoryId=44008&amp;ref=25</link>

    <description>Berlin, Germany, will host the XXVI Congress of the European Society of Cataract and Refractive
    Surgeons from Sept. 13 to 17. The annual meeting will feature a diverse agenda that includes symposia, a workshop
    on visual optics, training courses, and exhibits.</description>

    <dc:date>2008-08-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/322008/533857null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Orchestrating-international-health/ArticleStandard/Article/detail/530363?contextCategoryId=44008&amp;ref=25">

    <title>Orchestrating international health</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology+Feature/Orchestrating-international-health/ArticleStandard/Article/detail/530363?contextCategoryId=44008&amp;ref=25</link>

    <description>Dr. Lass, a corneal surgeon in Cleveland, OH, has organized and performed in concerts at ophthalmology
    and vision research meetings, including the American Academy of Ophthalmology (AAO) and the Association for
    Research in Vision and Ophthalmology (ARVO).</description>

    <dc:date>2008-07-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/292008/530363null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Insurance-deductibles-the-impact-on-patient-care/ArticleStandard/Article/detail/526998?contextCategoryId=44008&amp;ref=25">

    <title>Insurance deductibles: the impact on patient care</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Insurance-deductibles-the-impact-on-patient-care/ArticleStandard/Article/detail/526998?contextCategoryId=44008&amp;ref=25</link>

    <description>A review of the RAND Health Insurance Experiment results reveals that many of its conclusions are
    relevant today.</description>

    <dc:date>2008-07-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/272008/526998null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Survey-assesses-life-quality-for-adults-with-strab/ArticleStandard/Article/detail/526997?contextCategoryId=44008&amp;ref=25">

    <title>Survey assesses life quality for adults with strabismus</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Survey-assesses-life-quality-for-adults-with-strab/ArticleStandard/Article/detail/526997?contextCategoryId=44008&amp;ref=25</link>

    <description>A 20-item questionnaire is expected to be useful for evaluating the health-related quality of life of
    adults with strabismus and practical application in a clinical setting. The patient-derived questionnaire assesses
    both psychosocial and functional aspects of strabismus.</description>

    <dc:date>2008-07-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/272008/526997null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Vision-loss-studies-aim-to-optimize-future-care-fo/ArticleStandard/Article/detail/525445?contextCategoryId=44008&amp;ref=25">

    <title>Vision loss studies aim to optimize future care for patients with juvenile idiopathic arthritis-related
    uveitis</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Vision-loss-studies-aim-to-optimize-future-care-fo/ArticleStandard/Article/detail/525445?contextCategoryId=44008&amp;ref=25</link>

    <description>Uveitis associated with juvenile idiopathic arthritis can result in significant vision loss. Systemic
    immunosuppressive therapy may protect against that outcome. Identifying predictors of ocular complications and
    vision loss may help to select patients who can best benefit from aggressive medical treatment.</description>

    <dc:date>2008-06-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262008/525445null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Through-the-eyes-of-a-collector/ArticleStandard/Article/detail/525464?contextCategoryId=44008&amp;ref=25">

    <title>Through the eyes of a collector</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/Through-the-eyes-of-a-collector/ArticleStandard/Article/detail/525464?contextCategoryId=44008&amp;ref=25</link>

    <description>Ronald Linde, MD, an ophthalmologist in private practice in Northfield, MN, went to an auction in
    Nebraska more than 30 years ago to buy a table. Dr. Linde remembers this because it was at this auction that he
    discovered and purchased a stoneware jug that was the first piece in a now expansive collection of
    pottery.</description>

    <dc:date>2008-06-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262008/525464null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/New-tool-extends-patient-education-process-beyond-/ArticleStandard/Article/detail/525446?contextCategoryId=44008&amp;ref=25">

    <title>New tool extends patient education process beyond physicians' walls</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/New-tool-extends-patient-education-process-beyond-/ArticleStandard/Article/detail/525446?contextCategoryId=44008&amp;ref=25</link>

    <description>Many ophthalmologists are familiar with Eyemaginations' 3D-Eye in-office educational tools. Now, a
    home version is available that lets you extend your patient education reach beyond the walls of your office and
    into your patients' homes.</description>

    <dc:date>2008-06-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262008/525446null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/K7WX-calling/ArticleStandard/Article/detail/522120?contextCategoryId=44008&amp;ref=25">

    <title>K7WX calling</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/General+Ophthalmology/K7WX-calling/ArticleStandard/Article/detail/522120?contextCategoryId=44008&amp;ref=25</link>

    <description>Warren Hill, MD, an ophthalmologist in private practice in Mesa, AZ, learned when he was in his teens
    that the world isn't really all that big. His junior high hobby of contacting people around the world using amateur
    radio&amp;amp;mdash;called &amp;#34;DX&amp;#34; or &amp;#34;DXing&amp;#34;&amp;amp;mdash;later developed into a
    passion for traveling the world and using Morse code to communicate with whomever he can.</description>

    <dc:date>2008-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/232008/522120null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>
</rdf:RDF>


